Dithranol, 99%, MP Biomedicals™

Catalog No.	Quantity
MP219150291	1 g
ICN19150283	0.25 g
ICN19150294	5 g

Catalog No. MP219150291 Supplier MP Biomedicals, Inc Supplier No. 0219150291

Description

Dithranol ≥99%, Yellow Powder

• Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile.
• It may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles.
• It may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer.
• Anthralin is a leukotriene biosynthesis inhibitor.
• Inhibits LTB4 ω-oxidation and disrupts mitochondria function.
• Anthralin is used in the treatment of psoriasis, as a fungicide, in the treatment of ringworm infections and in chronic dermatoses.

Specifications

Chemical Identifiers

• CAS: 1143-38-0
• Molecular Formula: C14H10O3
• Molecular Weight (g/mol): 226.23
• MDL Number: MFCD00053409
• InChI Key: NUZWLKWWNNJHPT-UHFFFAOYSA-N
• IUPAC Name: 1,8-dihydroxy-9,10-dihydroanthracen-9-one
• SMILES: OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2

• Melting Point: 175°C to 182°C
• Color: Yellow
• Loss on Drying: 0.00256
• Quantity: 1 g
• Beilstein: 2054360
• Synonym: Anthralin, 1,8 Dihydroxyanthrone, 1,8,9-Anthracenetriol, 1,8-Dihydroxy-9(10H)-anthracenone
• Solubility Information: Soluble in chlororform (20mg/mL - clear, bright yellow solution) and in fixed oilds; slightly soluble in ethanol (95%) and in ether; practically insoluble in water.
• Physical Form: Powder
• Grade: >99%

Safety and Handling

RTECSNumber	CB8927000
storageNote1	Store at Room Temperature (15-30°C).